Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3540853
Reference Type
Journal Article
Title
In vitro cytotoxic effects of DEHP-alternative plasticizers and their primary metabolites on a L929 cell line
Author(s)
Eljezi, T; Pinta, P; Richard, D; Pinguet, J; Chezal, JM; Chagnon, MC; Sautou, V; Grimandi, G; Moreau, E
Year
2017
Is Peer Reviewed?
Yes
Journal
Chemosphere
ISSN:
0045-6535
EISSN:
1879-1298
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Location
OXFORD
Volume
173
Issue
Elsevier
Page Numbers
452-459
Language
English
PMID
28129623
DOI
10.1016/j.chemosphere.2017.01.026
Web of Science Id
WOS:000395213700052
URL
https://search.proquest.com/docview/1862764170?accountid=171501
Exit
Abstract
Phthalic acid esters have been widely used to improve the plasticity of PVC medical devices. They carry a high exposure risk for both humans and the environment in clinical situations. Our study focuses on the cytotoxicity of alternative plasticizers. Postulated primary metabolites were synthesized, not being commercially available. Cytotoxicity assays were performed on L929 murine cells according to the ISO-EN 10993-5 standard design for the biocompatibility of medical devices. The tested concentrations of plasticizers (0.01, 0.05 and 0.1 mg/ml) covered the range likely to be found in biological fluids coming into direct contact with the medical devices. DEHP, DINP and DINCH were cytotoxic at the highest concentration (0.1 mg/ml) for 7 days of exposure. Their corresponding metabolites were found to be more cytotoxic, for the same concentration. By contrast, TOTM and its corresponding metabolite MOTM were not found to be cytotoxic. DEHA showed no cytotoxicity, but its corresponding monoester (MEHA) produced a cytotoxic effect at 0.05 mg/ml. In clinical situations, medical devices can release plasticizers, which can come into contact with patients. In vivo, the plasticizers are quickly transformed into primary metabolites. It is therefore important to measure the effects of both the plasticizers and their corresponding metabolites. Standard first-line cytotoxicity assays should be performed to ensure biocompatibility.
Keywords
Animals; Cell Survival/drug effects; Cells, Cultured; Diethylhexyl Phthalate/adverse effects/metabolism; Esters/metabolism; Fibroblasts/drug effects/pathology; In Vitro Techniques; Phthalic Acids/metabolism; Plasticizers/adverse effects/metabolism; Polyvinyl Chloride/metabolism; Cytotoxicity; DEHP-alternative plasticizers; Metabolite synthesis; Phthalates; Plasticizers
Tags
IRIS
•
Diisononyl Phthalate (DINP)
Literature Search
LitSearch Jul 2016 - Jan 2017 Update
Considered new
PubMed
Toxline
LitSearch Jan 2017 - July 2017 Update
Prior search overlap
PubMed
Toxline
WoS
Studies with Supporting Data
Mechanistic and genotoxicity studies
•
Phthalates – Targeted Search for Epidemiological Studies
Source – all searches
Pubmed
WOS
Excluded
Source - August 2017 Update (Private)
Pubmed
WOS
Source - August 2018 Update
WOS
Level 1 Screen - Title & Abstract
Excluded
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity